Kalvista Pharmaceuticals Inc (OQ:KALV)

Business Focus: Biopharmaceuticals

Competitors with Recent Insider Filings
BioMarin Pharmaceutical (OQ:BMRN)
Aptinyx (OQ:APTX)
Biogen (OQ:BIIB)
Latest 10 SEC filings (by transaction date) for KALV within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Sep 12/18 Sep 10/18 Oronsky Arnold L Indirect Ownership Common Stock P - Open market or private purchase 58,824 $17.00
Sep 12/18 Sep 10/18 Cha Albert Indirect Ownership Common Stock P - Open market or private purchase 1,058,824 $17.00
Sep 10/18 Sep 10/18 Venrock Healthcare Capital Partners II, L.P. Indirect Ownership Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
Jun 6/18 Jun 4/18 Maetzel Andreas Direct Ownership Employee Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 20,700  
Jun 6/18 Jun 4/18 Feener Edward P. Direct Ownership Employee Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 51,800  
Jun 6/18 Jun 4/18 Palleiko Benjamin L Direct Ownership Employee Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 71,700  
Jun 6/18 Jun 4/18 Yea Christopher Direct Ownership Employee Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 53,500  
Jun 6/18 Jun 4/18 Crockett Thomas Andrew Direct Ownership Employee Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 130,800  
Oct 12/17 Oct 12/17 Novo Holdings A/S Direct Ownership Common Stock S - Open market or private sale -1,726,000 $8.50
Oct 12/17 Oct 12/17 Novo Holdings A/S Direct Ownership Common Stock S - Open market or private sale -481 $10.02
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Latest 10 SEC filings (by filing date) for KALV within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Sep 12/18 Sep 10/18 Oronsky Arnold L Indirect Ownership Common Stock P - Open market or private purchase 58,824 $17.00
Sep 12/18 Sep 10/18 Cha Albert Indirect Ownership Common Stock P - Open market or private purchase 1,058,824 $17.00
Sep 10/18 Sep 10/18 Venrock Healthcare Capital Partners II, L.P. Indirect Ownership Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
Jun 6/18 Jun 4/18 Maetzel Andreas Direct Ownership Employee Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 20,700  
Jun 6/18 Jun 4/18 Feener Edward P. Direct Ownership Employee Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 51,800  
Jun 6/18 Jun 4/18 Palleiko Benjamin L Direct Ownership Employee Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 71,700  
Jun 6/18 Jun 4/18 Yea Christopher Direct Ownership Employee Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 53,500  
Jun 6/18 Jun 4/18 Crockett Thomas Andrew Direct Ownership Employee Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 130,800  
Oct 19/17 Oct 12/17 Aldrich Richard Indirect Ownership Common Stock P - Open market or private purchase 565,065 $8.61
Oct 16/17 Oct 12/17 Ra Capital Management, Llc Indirect Ownership Common Stock P - Open market or private purchase 850,000 $8.50
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Sign up for a free account or login above to see the past 6 months of filings sorted by insider. During our beta offer, get free access to company PDF reports.
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $KALV

StockTwits